Business
Medtronic Diabetes expands access to full-stack insulin delivery solutions with Medicare access and new FDA clearances
Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced three significant U.S. milestones that expand access, choice, and flexibility for people living with type 1 and insulin‑requiring type 2 diabetes. These milestones include Medicare access for the MiniMed™ 780G system paired with the Instinct sensor, made by Abbott, FDA clearance for the system's use with ultra rapid‑acting insulins, and clearance of the MiniMed™ 780G system for use with the Instinct sensor for insul
About this update from Medtronic Plc.
[{"type":"text","content":"GALWAY, Ireland, Feb. 2, 2026 /PRNewswire/ -- Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced three significant U.S. milestones that expand access, choice, and flexibility for people living with type 1 and insulin‑requiring type 2 diabetes. These milestones include Medicare access for the MiniMed™ 780G system paired with the Instinct sensor, made by Abbott, FDA clearance for the system's use with ultra rapid‑acting insulins, and clearance of the MiniMed™ 780G system for use with the Instinct sensor for insulin-requiring type 2 diabetes.","length":585,"tagName":"p"},{"type":"image","alt":"Medtronic Diabetes expands access to full-stack insulin delivery solutions with Medicare access and new FDA clearances","displaySize":"","headline":null,"caption":"Medtronic Diabetes expands access to full-stack insulin delivery solutions with Medicare access and new FDA clearances","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":400,"url":"https://media.zenfs.com/en/prnewswire.com/510c2e1f8106182542990a1d044f35de"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/eElHG_TyUG3m.l6lII3SBQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTU2MDtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/510c2e1f8106182542990a1d044f35de","width":300,"height":400}},"href":"https://mma.prnewswire.com/media/2874765/Medtronic.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":""These milestones reflect our unwavering commitment to expanding access and giving individuals living with diabetes more choice in how they manage their condition," said Que Dallara, EVP & president, Medtronic Diabetes. "By broadening sensor and insulin options for the MiniMed™ 780G system, we're empowering more people to benefit from automated insulin delivery that supports easier mealtimes, greater flexibility, and more confident diabetes management—making everyday life a bit easier."","length":519,"tagName":"p"},{"type":"text","content":"Medicare Access for MiniMed™ 780G System with Instinct Sensor, Made by AbbottMedicare and Medicare Advantage beneficiaries can now access the MiniMed™ 780G system with the Instinct sensor, made by Abbott. The Instinct sensor is small, thin, and worn discreetly, with up to 15 days of wear. This milestone expands sensor choice for Medicare use...